908 Devices Inc. Common Stock vs. 10x Genomics, Inc. Class A Common Stock
MASS
908 Devices Inc. Common Stock
$10.73 -3.33%
VS TXG10x Genomics, Inc. Class A Common Stock
$61.54 -5.10%
10x Genomics, Inc. Class A Common Stock (TXG) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| MASS | TXG | |
|---|---|---|
| Market Cap | $443.51 million | $8.45 billion |
| Revenue (TTM) | $60.84 million | $616.91 million |
| Net Income (TTM) | $-34,657,000 | $-75,125,000 |
TXG leads on 2 of 3 size & scale factors.
Valuation
| MASS | TXG | |
|---|---|---|
| Price / Book | 3.50 | 10.23 |
| Price / Sales | 7.29 | 13.70 |
MASS leads on 2 of 2 valuation factors.
Profitability
| MASS | TXG | |
|---|---|---|
| Net Margin | -56.96% | -12.18% |
| Return on Equity | -27.34% | -9.10% |
TXG leads on 2 of 2 profitability factors.
Risk & Sentiment
| MASS | TXG | |
|---|---|---|
| Short Interest | 0.62% | 0.42% |
TXG leads on 1 of 1 risk & sentiment factors.
Dig deeper: MASS overview, MASS financials, TXG overview, TXG financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.